Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dr. Stephen Spielberg to Host Prominent Professionals at DIA EuroMeeting 2013

Published: Thursday, February 28, 2013
Last Updated: Wednesday, February 27, 2013
Bookmark and Share
DIA Europe’s 25th Annual EuroMeeting to be held in Amsterdam from 4-6 March, 2013.

Dr. Stephen Spielberg, M.D., Ph.D., Editor-in-Chief of DIA’s peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS), will be meeting high-profile industry experts from around the world at DIA Europe’s 25th Annual EuroMeeting in Amsterdam from 4-6 March, 2013.

Dr. Spielberg will welcome EuroMeeting 2013 participants at the DIA’s exhibition booth on Monday 4 March.

Then, on 6 March, a host of prominent industry experts, including representatives from the European Medicines Agency (EMA) and the Directorate General for Health and Consumer Affairs (DG SANCO), will be invited to a meet and greet breakfast and a TIRS Editorial lunch.

Dr. Spielberg said: “I am greatly looking forward to welcoming participants to the EuroMeeting 2013 in Amsterdam. This year promises to be an insightful event with 110 comprehensive sessions.”

More than 300 high-profile speakers, moderators, and panelists from around the world are set to attend EuroMeeting 2013, substantiating the meeting’s claim to being the most important event in the medicines development calendar.

The meeting will feature 200 exhibitors and bring together professionals from the biopharmaceutical industry, contract research and service organizations, academic research centres, health ministries, and delegates from patient organizations to share knowledge focusing on better public health protection, greater transparency of processes, and the rational use of medicinal products.

For more information about the event visit

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos